Literature DB >> 23261783

Matrix metalloproteinase-28 deletion exacerbates cardiac dysfunction and rupture after myocardial infarction in mice by inhibiting M2 macrophage activation.

Yonggang Ma1, Ganesh V Halade, Jianhua Zhang, Trevi A Ramirez, Daniel Levin, Andrew Voorhees, Yu-Fang Jin, Hai-Chao Han, Anne M Manicone, Merry L Lindsey.   

Abstract

RATIONALE: Matrix metalloproteinase (MMP)-28 regulates the inflammatory and extracellular matrix responses in cardiac aging, but the roles of MMP-28 after myocardial infarction (MI) have not been explored.
OBJECTIVE: To determine the impact of MMP-28 deletion on post-MI remodeling of the left ventricle (LV). METHODS AND
RESULTS: Adult C57BL/6J wild-type (n=76) and MMP null (MMP-28((-/-)), n=86) mice of both sexes were subjected to permanent coronary artery ligation to create MI. MMP-28 expression decreased post-MI, and its cell source shifted from myocytes to macrophages. MMP-28 deletion increased day 7 mortality because of increased cardiac rupture post-MI. MMP-28(-/-) mice exhibited larger LV volumes, worse LV dysfunction, a worse LV remodeling index, and increased lung edema. Plasma MMP-9 levels were unchanged in the MMP-28((-/-)) mice but increased in wild-type mice at day 7 post-MI. The mRNA levels of inflammatory and extracellular matrix proteins were attenuated in the infarct regions of MMP-28(-/-) mice, indicating reduced inflammatory and extracellular matrix responses. M2 macrophage activation was impaired when MMP-28 was absent. MMP-28 deletion also led to decreased collagen deposition and fewer myofibroblasts. Collagen cross-linking was impaired as a result of decreased expression and activation of lysyl oxidase in the infarcts of MMP-28(-/-) mice. The LV tensile strength at day 3 post-MI, however, was similar between the 2 genotypes.
CONCLUSIONS: MMP-28 deletion aggravated MI-induced LV dysfunction and rupture as a result of defective inflammatory response and scar formation by suppressing M2 macrophage activation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23261783      PMCID: PMC3597388          DOI: 10.1161/CIRCRESAHA.111.300502

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  55 in total

1.  Epilysin (MMP-28) induces TGF-beta mediated epithelial to mesenchymal transition in lung carcinoma cells.

Authors:  Sara A Illman; Kaisa Lehti; Jorma Keski-Oja; Jouko Lohi
Journal:  J Cell Sci       Date:  2006-08-29       Impact factor: 5.285

2.  Factor XIII deficiency causes cardiac rupture, impairs wound healing, and aggravates cardiac remodeling in mice with myocardial infarction.

Authors:  Matthias Nahrendorf; Kai Hu; Stefan Frantz; Farouc A Jaffer; Ching-Hsuan Tung; Karl-Heinz Hiller; Sabine Voll; Peter Nordbeck; David Sosnovik; Stefan Gattenlöhner; Mikhail Novikov; Gerhard Dickneite; Guy L Reed; Peter Jakob; Anthony Rosenzweig; Wolfgang R Bauer; Ralph Weissleder; Georg Ertl
Journal:  Circulation       Date:  2006-02-27       Impact factor: 29.690

3.  Matrix metalloproteinase-7 affects connexin-43 levels, electrical conduction, and survival after myocardial infarction.

Authors:  Merry L Lindsey; G Patricia Escobar; Rupak Mukherjee; Danielle K Goshorn; Nina J Sheats; James A Bruce; I Matthew Mains; Jennifer K Hendrick; Kenneth W Hewett; Robert G Gourdie; Lynn M Matrisian; Francis G Spinale
Journal:  Circulation       Date:  2006-06-12       Impact factor: 29.690

4.  Sensitive fluorimetric quantitation of pyridinium and pentosidine crosslinks in biological samples in a single high-performance liquid chromatographic run.

Authors:  R A Bank; B Beekman; N Verzijl; J A de Roos; A N Sakkee; J M TeKoppele
Journal:  J Chromatogr B Biomed Sci Appl       Date:  1997-12-05

5.  Mouse model of post-infarct ventricular rupture: time course, strain- and gender-dependency, tensile strength, and histopathology.

Authors:  Xiao-Ming Gao; Qi Xu; Helen Kiriazis; Anthony M Dart; Xiao-Jun Du
Journal:  Cardiovasc Res       Date:  2005-02-01       Impact factor: 10.787

6.  Matrix metalloproteinase-9 gene deletion facilitates angiogenesis after myocardial infarction.

Authors:  Merry L Lindsey; G Patricia Escobar; Lawrence W Dobrucki; Danielle K Goshorn; Shenikqua Bouges; Joseph T Mingoia; David M McClister; Haili Su; Joseph Gannon; Catherine MacGillivray; Richard T Lee; Albert J Sinusas; Francis G Spinale
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-08-26       Impact factor: 4.733

7.  Excessive tumor necrosis factor activation after infarction contributes to susceptibility of myocardial rupture and left ventricular dysfunction.

Authors:  Mei Sun; Fayez Dawood; Wen-Hu Wen; Manyin Chen; Ian Dixon; Lorrie A Kirshenbaum; Peter P Liu
Journal:  Circulation       Date:  2004-11-08       Impact factor: 29.690

8.  Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction.

Authors:  Shunji Hayashidani; Hiroyuki Tsutsui; Masaki Ikeuchi; Tetsuya Shiomi; Hidenori Matsusaka; Toru Kubota; Kyoko Imanaka-Yoshida; Takeshi Itoh; Akira Takeshita
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-05-29       Impact factor: 4.733

9.  Myocardial infarction in the C57BL/6J mouse: a quantifiable and highly reproducible experimental model.

Authors:  Manuel Salto-Tellez; Sing Yung Lim; Reida Menshawe El-Oakley; Tiffany Pooi Ling Tang; Zakaria Ali Moh ALmsherqi; Sai-Kiang Lim
Journal:  Cardiovasc Pathol       Date:  2004 Mar-Apr       Impact factor: 2.185

10.  Infarct size and post-infarct inflammation determine the risk of cardiac rupture in mice.

Authors:  Xiao-Ming Gao; Ziqiu Ming; Yidan Su; Lu Fang; Helen Kiriazis; Qi Xu; Anthony M Dart; Xiao-Jun Du
Journal:  Int J Cardiol       Date:  2009-02-04       Impact factor: 4.164

View more
  108 in total

Review 1.  Matrix metalloproteinases as input and output signals for post-myocardial infarction remodeling.

Authors:  Merry L Lindsey; Rugmani Padmanabhan Iyer; Mira Jung; Kristine Y DeLeon-Pennell; Yonggang Ma
Journal:  J Mol Cell Cardiol       Date:  2015-12-23       Impact factor: 5.000

2.  Secreted protein acidic and rich in cysteine facilitates age-related cardiac inflammation and macrophage M1 polarization.

Authors:  Hiroe Toba; Lisandra E de Castro Brás; Catalin F Baicu; Michael R Zile; Merry L Lindsey; Amy D Bradshaw
Journal:  Am J Physiol Cell Physiol       Date:  2015-04-15       Impact factor: 4.249

Review 3.  Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.

Authors:  Xi Wang; Raouf A Khalil
Journal:  Adv Pharmacol       Date:  2017-09-19

4.  Cardiac aging is initiated by matrix metalloproteinase-9-mediated endothelial dysfunction.

Authors:  Andriy Yabluchanskiy; Yonggang Ma; Ying Ann Chiao; Elizabeth F Lopez; Andrew P Voorhees; Hiroe Toba; Michael E Hall; Hai-Chao Han; Merry L Lindsey; Yu-Fang Jin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-03-21       Impact factor: 4.733

Review 5.  Matrix metalloproteinases in emphysema.

Authors:  Sina A Gharib; Anne M Manicone; William C Parks
Journal:  Matrix Biol       Date:  2018-03-23       Impact factor: 11.583

Review 6.  Role of interleukin-6 in regulation of immune responses to remodeling after myocardial infarction.

Authors:  Mingyuan Huang; Du Yang; Meixiang Xiang; Jianan Wang
Journal:  Heart Fail Rev       Date:  2015-01       Impact factor: 4.214

Review 7.  Assigning matrix metalloproteinase roles in ischaemic cardiac remodelling.

Authors:  Merry L Lindsey
Journal:  Nat Rev Cardiol       Date:  2018-08       Impact factor: 32.419

Review 8.  Mechanobiology of myofibroblast adhesion in fibrotic cardiac disease.

Authors:  Alison K Schroer; W David Merryman
Journal:  J Cell Sci       Date:  2015-04-27       Impact factor: 5.285

9.  Quantification of MicroRNAs by Coupling Cyclic Enzymatic Amplification with Microfluidic Voltage-Assisted Liquid Desorption Electrospray Ionization Mass Spectrometry.

Authors:  Xiangtang Li; Pratik Rout; Rui Xu; Li Pan; Paul B Tchounwou; Yonggang Ma; Yi-Ming Liu
Journal:  Anal Chem       Date:  2018-11-06       Impact factor: 6.986

10.  Targeted Injection of a Truncated Form of Tissue Inhibitor of Metalloproteinase 3 Alters Post-Myocardial Infarction Remodeling.

Authors:  David C Lobb; Heather Doviak; Gregory L Brower; Eva Romito; Jason W O'Neill; Stephen Smith; James A Shuman; Parker D Freels; Kia N Zellars; Lisa A Freeburg; Aarif Y Khakoo; TaeWeon Lee; Francis G Spinale
Journal:  J Pharmacol Exp Ther       Date:  2020-09-21       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.